Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjell-Morten Myhr

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Journal of the Neurological Sciences|June 25, 2009
Vitamin D treatment in multiple sclerosisKjell-Morten Myhr
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 13, 2010
[Pharmacological treatment of multiple sclerosis]Kjell-Morten Myhr
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 3, 2005
[Epidemiological data on multiple sclerosis]Kjell-Morten Myhr
Acta Neurologica Scandinavica. Supplementum|June 18, 2008
Diagnosis and treatment of multiple sclerosisKjell-Morten Myhr
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2019
Serum NFL levels should be used to monitor multiple sclerosis evolution - NoKjell-Morten Myhr, Øivind Torkildsen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 2026
Kjell-Morten Myhr, Øivind Torkildsen
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 13, 2013
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: noJonatan Salzer, Kjell-Morten Myhr
Journal of Neurology|February 28, 2006
Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosisAntonie Giaever Beiske, Kjell-Morten Myhr
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 6, 2003
[Multiple sclerosis--a disease with complex genetics]Kjell-Morten Myhr, Hanne Flinstad Harbo
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 11, 2014
[Re: Unethical of neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support]Trygve Holmøy, Kjell-Morten Myhr, Lars Bø
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Journal of the Neurological Sciences|June 25, 2009
Vitamin D treatment in multiple sclerosisKjell-Morten Myhr
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 13, 2010
[Pharmacological treatment of multiple sclerosis]Kjell-Morten Myhr
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 3, 2005
[Epidemiological data on multiple sclerosis]Kjell-Morten Myhr
Acta Neurologica Scandinavica. Supplementum|June 18, 2008
Diagnosis and treatment of multiple sclerosisKjell-Morten Myhr
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2019
Serum NFL levels should be used to monitor multiple sclerosis evolution - NoKjell-Morten Myhr, Øivind Torkildsen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 2026
Kjell-Morten Myhr, Øivind Torkildsen
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 13, 2013
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: noJonatan Salzer, Kjell-Morten Myhr
Journal of Neurology|February 28, 2006
Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosisAntonie Giaever Beiske, Kjell-Morten Myhr
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 6, 2003
[Multiple sclerosis--a disease with complex genetics]Kjell-Morten Myhr, Hanne Flinstad Harbo
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 11, 2014
[Re: Unethical of neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support]Trygve Holmøy, Kjell-Morten Myhr, Lars Bø
Pageof 21